1,112 results on '"Hide, Michihiro"'
Search Results
52. Sweat allergy
53. A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative
54. Time Course of Priming Effect of TF Inducers on Synergistic TF Expression and Intra-Cellular Gap Formation of Human Vascular Endothelial Cells via the Extrinsic Coagulation Cascade
55. Efficacy and safety of omalizumab for the treatment of refractory chronic spontaneous urticaria in Japanese patients: Subgroup analysis of the phase 3 POLARIS study
56. Chronic spontaneous urticaria and the extrinsic coagulation system
57. The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update
58. Different hypersensitivities against homologous proteins of MGL_1304 in patients with atopic dermatitis
59. Role of TF-Triggered Activation of the Coagulation Cascade in the Pathogenesis of Chronic Spontaneous Urticaria
60. Staphylococcus aureus from atopic dermatitis skin alters cytokine production triggered by monocyte-derived Langerhans cell
61. Basophil Characteristics as a Marker of the Pathogenesis of Chronic Spontaneous Urticaria in Relation to the Coagulation and Complement Systems
62. A single-blind, randomized, crossover study on the efficacy of icatibant for sweating-induced dermal pain (icatibant for sweating-induced dermal pain)
63. ISID1357 - Construction of the atopic dermatitis sweat function registry (ADSF Registry) for sweating disturbance in atopic dermatitis evaluated by automatic assessment for skin microstructure and sweating.
64. Remibrutinib: A Novel BTKi in Development for MS With a Favorable Safety Profile in Various Autoimmune Disorders (P7-3.015)
65. Pustular eruption on the palms and soles associated with zinc allergy and perspiration.
66. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
67. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan
68. Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria
69. Sweat allergy: Extrinsic or intrinsic?
70. Analysis of primary treatment and prognosis of spontaneous urticaria
71. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study
72. Sensitization against skin resident fungi is associated with atopy in cholinergic urticaria patients
73. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial
74. Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open‐label study.
75. Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open‐label study.
76. English version of Japanese guidance for biologics in treating atopic dermatitis.
77. Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol
78. Environmental factors associated with childhood eczema: Findings from a national web-based survey
79. Burden of illness seen in hereditary angioedema in Japanese patients: Results from a patient reported outcome survey
80. ヒト血管内皮細胞における相乗的組織因子発現に対する組織因子誘発物質の時間解析
81. The Toll-like receptor 4-activated neuroprotective microglia subpopulation survives via granulocyte macrophage colony-stimulating factor and JAK2/STAT5 signaling
82. Evaluation of recombinant MGL_1304 produced by Pichia pastoris for clinical application to sweat allergy
83. Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B‐PAD study)
84. Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances
85. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan
86. Concise update on the pathogenesis of chronic spontaneous urticaria (CSU)
87. Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey
88. The expression of prolyl isomerase Pin1 is expanded in the skin of patients with atopic dermatitis and facilitates IL ‐33 expression in HaCaT cells
89. Mathematical-structure based Morphological Classification of Skin Eruptions and Linking to the Pathophysiological State of Chronic Spontaneous Urticaria
90. Faculty Opinions recommendation of IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms.
91. Faculty Opinions recommendation of IgE receptor responsiveness of basophils in chronic inducible urticaria.
92. Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study
93. Clinical diagnosis of type I allergy by means of SPR imaging with less than a microliter of peripheral blood
94. Chronic Urticaria as an Autoimmune Disease
95. Basophils activation of patients with chronic spontaneous urticaria in response to C5a despite failure to respond to IgE-mediated stimuli
96. 33586 Complete freedom from chronic spontaneous urticaria signs and symptoms is associated with sleep and dermatology quality-of-life improvements: Data from the phase 2b ligelizumab study
97. Classification of Skin Injury Risk Caused by Extravasation of Electrolyte Solutions or Infusions in a Rat Model
98. A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan
99. Propylthiouracil-induced Alopecia Accompanying Hypohidrosis and Onychomadesis
100. English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.